Dental Sale Earnouts and Equity Rollovers Explained (2026)
Only 60% to 80% of a group buyer’s offer is cash at closing. The rest arrives later, if it arrives, and understanding that gap is the whole game.
- Money tied to targets gets measured over 12 to 36 months, usually two years.
- A stake in their company takes 15% to 40% of your price and locks it up for five to seven years.
- You stop controlling the practice at closing, but you keep carrying the risk on both.
Money Tied to Targets
Part of your price gets paid after closing, but only if the practice hits agreed numbers. Usually profit, production, or your associates staying.
- The period: 12 to 36 months, and two years is the common one.
- The size: usually whatever is left after the cash and the stake.
- The measure: profit retained, collections, production, or whether your associates are still there.
How Common This Is
Across private company sales of every kind, 24% carried money tied to targets in 2025, up from 19% in 2014.
The Problem With That
You sold the practice. You do not set the fees, the schedule, the staffing, or the suppliers any more. They do.
If their changes slow production down, you can miss targets that were realistic when you signed. A three-year period carries far more of this risk than a one-year period.
Money paid in later years usually falls under the IRS installment sale rules. Ask your accountant how that timing hits you.
The Associate Trap
Dental targets are often tied to your associates staying put. If one leaves during the handover, you can lose money you thought was yours.
That is why getting them under contract before you go to market is one of the highest-value things you can do.
What to Negotiate Instead
- Get paid for partial performance. Hitting 90% of a target should pay 90%, not nothing.
- Lock down how profit is calculated, in writing, so their overhead cannot be allocated onto your number.
- Carve out their own changes. If their new fee schedule cuts production, that should not cost you.
- Get paid in full if they sell. Many agreements are silent on this, which means you can lose the balance.
The Stake You Keep in Their Company
Instead of taking all cash, you leave 15% to 40% of your price invested in the buyer’s parent company.
The pitch is a second payday. When they sell to the next investor in three to seven years, your slice sells too.
- Your slice is small. Often 1% to 5% of the parent, depending on your size against theirs.
- If they grow and sell well, it can be worth two or three times what you left in.
- If they stumble, it can be worth very little, and you cannot get out early.
The Risks Sellers Miss
- You cannot spend it. It is locked until their next sale, on their schedule, not yours.
- You can lose it. Leaving on bad terms can trigger a forced buyout at a lower value, or forfeiture.
- You get no vote on timing. Plenty of sellers assume otherwise, and find out late.
- It can shrink. Without protection, later fundraising dilutes your slice.
- It helps them first. Every dollar you roll is a dollar they did not have to pay you, and it keeps you invested in their results.
What to Ask For
- The right to sell when they sell, on the same terms.
- The right to make them buy you out at agreed terms after a set period.
- Quarterly numbers, so you can see whether your slice is worth anything.
- Protection from dilution when they raise more money.
Why a $5M Offer Is Not $5M
| Part of the Offer | Usual Share | On $5M | The Risk |
|---|---|---|---|
| Cash at closing | 60% to 80% | $3M to $4M | None, it is in your account |
| Tied to targets | 10% to 20% | $500K to $1M | Depends on numbers you no longer control |
| Your stake | 10% to 30% | $500K to $1.5M | Locked up for five to eight years |
| If their sale goes well | 2x to 4x your stake | $1M to $6M | Entirely down to how they perform |
So $3.5M is real. The other $1.5M is a set of maybes with very different odds attached.
Across all deals carrying money tied to targets, about one dollar in five actually gets paid. Price that part as a fraction of its headline. Your floor is the $3.5M in cash.
That is why comparing this to an offer from another dentist on headline numbers alone misleads you. See associate versus group for the comparison done properly.
All of This Is Decided in the Offer Letter
The structure gets set in the letter of intent, and most dentists sign that focused only on the big number.
The people across the table do this every week and know exactly which terms to present as standard.
Even non-binding terms stick. Once you have nodded at something, asking to change it later gets treated as bad faith.
- Settle it before you sign: how partial performance pays, how profit is calculated, what happens if they sell, and how you get out of the stake.
- By the time the full agreement arrives, your leverage is gone.
One Timing Trap in Each State
In New Jersey your buyer has to enroll with Medicaid and the insurers again, which takes months and can dent early production.
If your targets are measured over that same window, you are being judged on a period the paperwork is holding down. Ask for it to be excluded.
In Pennsylvania the delay lands before closing instead, with state tax clearance taking six to eight weeks.
Related Guides
- Before you weigh the stake you keep, check who is allowed to own a New York practice.
- What group buyers pay, and how that compares to an associate.
- Valuation by practice size, and how long a sale takes.
- Selling in Pennsylvania or New Jersey.
- The same offer letter fixes how the sale is taxed.
- Selling to another dentist instead? They usually borrow through the SBA’s main loan program, and pay you mostly in cash.
- These terms are negotiated quietly. Selling off market.
Frequently Asked Questions
Usually 60% to 80% at closing. Another 15% to 40% comes back as a stake in their company, and whatever is left depends on hitting targets. Only the cash at closing is certain.
Twelve to 36 months, and two years is the most common. The longer it runs, the more can change around you. Numbers that looked fine on signing day get harder to hit.
That is the core risk. New fees, new scheduling, new staffing, and new suppliers can all pull production down and cost you money tied to targets. Negotiate a carve-out for their own changes before you sign anything.
No. It pays when they sell to the next investor, usually in five to seven years. It can be worth two or three times what you left in, or very little if they underperform. You cannot cash it out in the meantime.
Yes. Leaving on bad terms, or breaching your agreement, can trigger a forced buyout at a reduced value or outright forfeiture. Ask for clear terms on what counts, and for the right to make them buy you out.
Four things. The right to sell when they sell. The right to force a buyout after a set period. Quarterly numbers, so you can see how they are doing. And protection from dilution when they raise more money.
Because it sets all of this: how targets are measured, how profit is calculated, and how your stake works. Even non-binding terms stick, and asking to change them later reads as bad faith. Argue it before you sign.
